CA
CASI Pharmaceuticals, Inc.
CASIF · OTC
$0.13 +0.00% (+$0.00)
1M +0.00%
Market Cap $2.65M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.13x
P/E N/A
P/FFO N/A
Growth
9 /100
Declining Rev. growth 1.84%
Book val. growth 72.02%
EPS growth N/A
Profitability
22 /100
Weak Gross margin 59.97%
FCF margin 0.00%
Net margin 218.55%
Quality
74 /100
Excellent ROIC 759.62%
Asset turnover 0.95x
ROA 208.70%
Debt
0 /100
High Current ratio 0.15x
Int. coverage -100.15x
Debt/Equity N/A
Stability
35 /100
Moderate Beta 1.40x
Profitable years 0
Rev. volatility 35.61%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CASIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Cory
Employees
214
Headquarters
Beijing
Upcoming events
25 SEP
Earnings
Upcoming earnings report
13 NOV
Earnings
Upcoming earnings report